Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Here's Why Teva Pharmaceutical Industries (NYSE:TEVA) Is Weighed Down By Its Debt Load - Simply Wall St News
Teva Pharmaceuticals has acquired success with Actavis Generics | World Finance
Teva Pharmaceuticals is found liable in the opioid crisis : NPR
Teva Announces $2,250,000,000 Debt Tender Offers for Notes Due 2023-2026 | Business Wire
Teva reaches opioid settlement, Credit Suisse names new CEO, Twitter to hold shareholder vote
Teva timeline: CEO says 20-25 manufacturing plants to close in next two years
Teva Reports Third Quarter 2022 Financial Results
Teva responds to Mylan backlash with planned launch of generic EpiPen | Healthcare Finance News
Teva Reports Fourth Quarter and Full Year 2022 Financial Results | Business Wire
Amit Hazan - Head of Corporate Finance & Banking Relations - Teva Pharmaceuticals | LinkedIn
Investors question green tint of Teva's $5bn sustainability bond | Financial Times
Jose Lassalle - Finance Manager - Teva Pharmaceuticals | LinkedIn
Teva | Partnership | Direct Relief
Teva (TEVA) Beats on Q3 Earnings, Lags Sales, Shares Up
Teva Announces Appointment of New Chief Financial Officer | BioSpace
Teva Pharmaceuticals on Twitter: "Teva Global Operations NA and Complex Manufacturing Finance Leader Mayra Avila shares how she confronted a challenge head-on to find her voice. Read her story and learn more
Teva Reports Fourth Quarter and Full Year 2019 Financial Results | Business Wire
Teva workers blockade Jerusalem industrial park as PM, CEO set to meet | The Times of Israel
Teva workers threaten to blow up Jerusalem factory in protest over layoffs | The Times of Israel
Teva Pharmaceuticals Industries Ltd. to buy Rimsa for $2.3 billion - Pittsburgh Business Times
Teva Reports First Quarter 2023 Financial Results and Reaffirms 2023 Non-GAAP Outlook
High Debt, Potential Litigation Costs Face New Teva CFO - WSJ
